权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Identification of Genetic Markers of Susceptibility to Intracellular Bacterial Infection Using the Collaborative Cross Mouse Model

使用协作交叉小鼠模型鉴定细胞内细菌感染易感性的遗传标记

基本信息

批准号：
10511530
负责人：
Elke BergmannLeitner
金额：
$ 21.54万
依托单位：
GENEVA FOUNDATION
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-08-01 至 2024-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10511530
关键词：
Animal Disease Models Animal Model Anti-Bacterial Agents Antigens Artificial Intelligence Bacteria Bacterial Infections Biological Markers Biological Models Body Temperature Body Weight decreased Boutonneuse Fever Cells Clinical Collaborations Communicable Diseases Computer Analysis Data Data Analyses Disease Disease susceptibility Exhibits Foundations Frequencies Future Gene Targeting Genes Genetic Genetic Determinism Genetic Markers Genetic Variation Genome Genomics Health Human Immune Immune response Immune system Immunity Immunologics Immunology Immunotherapeutic agent Inbred Mouse Inbreeding Individual Infection Interruption Intravenous Laboratories Lead Literature Liver Machine Learning Maryland Methods Mining Modeling Molecular Mouse Strains Mus Organ Outcome Output Pathology Phenotype Population Predisposition Prognostic Marker Public Health Quantitative Trait Loci Randomized Recombinants Research Research Personnel Resistance Resistance to infection Resolution Resources Rickettsia Rickettsia Infections Rickettsia conorii Rocky Mountain Spotted Fever Role Seminal Serum Spleen System Therapeutic Therapeutic Intervention Tick-Borne Diseases Time Universities Vaccines Variant Work acute infection adaptive immune response base bioinformatics tool biomarker identification chemokine cohort comparative genomics cytokine data integration diagnostic biomarker disease phenotype genetic analysis genetic approach genomic locus human disease human model human pathogen insight mouse genome mouse model multidisciplinary novel pathogen peripheral blood prophylactic resilience response reverse genetics targeted treatment therapeutic development therapeutic evaluation tick-borne tool trait transcriptomics vaccine development

项目摘要

PROJECT SUMMARY Identification of the genetic and molecular mechanisms governing immunity against intracellular bacteria is imperative for understanding the host-pathogen-interplay and forms the basis for the development of therapeutic countermeasures. Previous attempts at increasing our understanding of this topic have relied on targeted interruption of individual genes or analysis natural genetic variability in natural populations. Herein, we propose to employ 1) animal models with pre-defined genetic variability, 2) cutting edge immunoprofiling, 3) comparative genomics, and 4) computational analyses to identify the immunological and genetic basis of sensitivity to Rickettsia infection. This approach employs the collaborative cross (CC) mice. This mouse resource involves a cohort of recombinant-inbred lines generated by randomizing the genetic diversity of existing inbred mouse resources. This pre-defined genetic diversity has significantly accelerated discovery of genetic determinants that regulate immunity against several pathogens as well as other non-infectious diseases. The CC mouse resource is distinct from other animal models as its high genetic diversity is comparable to that of human populations. Unlike in outbred animal models, each CC line reproducibly exhibits distinct phenotypes of disease susceptibility and immune profiles to pathogens. Our multi-disciplinary team will screen CC lines to establish the range of responses to the tick-borne human pathogen Rickettsia conorii. Using murine models of Rickettsia infection with well-established phenotypic difference in susceptibility to infection, we will screen initially CC mouse lines to encompass a detailed assessment of the disease phenotype (bacterial load, weight loss, body temperature, survival) and immunoprofiling of peripheral blood, spleen, and liver as relevant, representative organ. CC lines with extreme clinical and immunological phenotypes will then be selected for longitudinal in-depth immunoprofiling. Here, changes in the frequency of activated innate and antigen-specific adaptive cells, cytokine profiles in serum, and antibacterial activities of immune cells will be assessed throughout infection and disease resolution. Computational data integration and bioinformatics tools (machine learning) will be applied to establish the immune landscape of Rickettsia-specific immune responses to identify immune correlates that govern disease phenotype of each CC line. The short-term impact of the proposed work will be the identification of novel murine models that emulate differential immune responses to infection. These tools will enable researchers to test therapeutics and/or vaccines in a diverse system that, for the first time, has the potential to forecast responses in humans. Computational analysis will be performed to identify quantitative trait loci associated with disease phenotype and disease-specific immunoprofiles. This information will be the basis for the future identification of genes responsible for immunity against intracellular bacteria, which will have a significant long- term impact on our understanding of multiple rickettsial diseases.

项目总结